Marketing-authorisation holder · Canada
Bayer Inc
316 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
316 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 316
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADALAT XL30 mg · Tablet (Extended-Release) | Nifedipine | Canada | Marketed | 1992 |
| ADEMPAS2.5 mg · Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS2 mg · Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS1 mg · Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS1.5 mg · Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS0.5 mg · Tablet | Riociguat | Canada | Marketed | 2013 |
| AERIUS0.5 mg / ml · Syrup | Desloratadine | Canada | Authorised | |
| AERIUS5 mg · Tablet | Desloratadine | Canada | Marketed | 2002 |
| AERIUS KIDS0.5 mg / ml · Syrup | Desloratadine | Canada | Marketed | 2005 |
| AERIUS SINUS + ALLERGY2.5 mg + 120 mg · Tablet (Extended-Release) | Desloratadine, Pseudoephedrine | Canada | Marketed | 2010 |
| AESB - OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION USP, 0.025%0.025 % · Solution | Oxymetazoline | Canada | Authorised | |
| ALEVE BACK AND BODY PAIN220 mg · Capsule | Naproxen | Canada | Marketed | 2015 |
| ALEVE CAPLETS220 mg · Tablet | Naproxen | Canada | Marketed | 2009 |
| ALEVE LIQUID GELS220 mg · Capsule | Naproxen | Canada | Marketed | 2011 |
| ALEVE NIGHTTIME25 mg + 220 mg · Tablet | Diphenhydramine, Naproxen | Canada | Marketed | 2016 |
| AMBELVIST257.9 mg / ml · Solution | Gadoquatrane | Canada | Authorised | |
| ANGELIQ1.0 mg + 1.0 mg · Tablet | Drospirenone, Estradiol | Canada | Marketed | 2008 |
| ASPIRIN 81MG81 mg · Tablet (Enteric-Coated) | Acetylsalicylic acid | Canada | Marketed | 1998 |
| ASPIRIN 81MG QUICK CHEWS81 mg · Tablet (Chewable) | Acetylsalicylic acid | Canada | Marketed | 2007 |
| ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH325 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 1995 |
| ASPIRIN EXTRA STRENGTH500 mg · Tablet | Acetylsalicylic acid | Canada | Marketed | 1995 |
| ASPIRIN REGULAR STRENGTH325 mg · Tablet | Acetylsalicylic acid | Canada | Marketed | 1970 |
| BETASERON0.3 mg / vial · Powder For Solution | Interferon beta-1a | Canada | Marketed | 1995 |
| CANESORAL150 mg · Capsule | Fluconazole | Canada | Marketed | 2010 |
| CANESORAL COMBI 1 DAY2 % / w/w + 150 mg / cap · Capsule, Cream | Clotrimazole, Fluconazole | Canada | Marketed | 2020 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 316 | 128 | 188 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.